Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc.

Acción · US0906783016 (OTC)
Resumen
Análisis impulsado por IA
Análisis fundamental
Descubre lo que realmente dicen los números — antes que el mercado
Analizar ahora
Sentimiento de noticias
¿Las noticias de hoy son una señal de compra o una alerta?
Analizar ahora
Comprar / Mantener / Vender
¿Comprar, mantener o vender? Obtén el veredicto de la IA ahora.
Analizar ahora
Evaluación de riesgos
Descubre riesgos ocultos antes de que afecten a tu cartera.
Analizar ahora
Valor justo
¿Esta acción está barata, correctamente valorada o sobrevalorada?
Analizar ahora
Últimos análisis de IA sobre Biostar Pharmaceuticals, Inc.
Sin cotización
Precio de cierre OTC 28.04.2026: 0,0001 USD
28.04.2026 20:00
Cotizaciones actuales de Biostar Pharmaceuticals, Inc.
BolsaTickerMonedaÚltima operaciónPrecioVariación diaria
OTC: UTC
UTC
BSPM
USD
28.04.2026 20:00
0,0001 USD
0,00 USD
Perfil de la empresa para Biostar Pharmaceuticals, Inc. Acción
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.

Datos de la empresa

Nombre Biostar Pharmaceuticals, Inc.
Empresa Biostar Pharmaceuticals, Inc.
Sitio web https://biostarpharmaceuticals.com
Mercado principal OTC UTC
ISIN US0906783016
Tipo de valor Acción
Sector Healthcare
Industria Drug Manufacturers - Specialty & Generic
CEO Ronghua Wang
País China
Moneda USD
Empleados 0,2 T
Dirección No. 588 Shiji Xi Road, 712000 Xianyang
Fecha de OPV 2008-12-18

Splits de acciones

Fecha Split
05.02.2016 1:7
04.04.2012 1:3

Símbolos de cotización

Nombre Símbolo
Over The Counter BSPM
Otras acciones
Los inversores que tienen Biostar Pharmaceuticals, Inc. también tienen las siguientes acciones en su cartera:
REP. FSE 16-47 O.A.T.
REP. FSE 16-47 O.A.T. Bono
WRTS LKD ORDS YES BNK 18/06/24
WRTS LKD ORDS YES BNK 18/06/24 Verbriefte Derivate